Potential amelioration of upregulated renal HIF-1alpha–endothelin-1 system by landiolol hydrochloride in a rat model of endotoxemia

Life Sciences

Volumn 118, Issue 2, 2014, Pages 347-356

  Ogura, Yoshiyasu ^a,b   Jesmin, Subrina ^a,b   Yamaguchi, Naoto ^a,b   Oki, Masami ^a,b   Shimojo, Nobutake ^a,b   Islam, Md Majedul ^a,b   Khatun, Tanzila ^a,b   Kamiyama, Junko ^a,b   Sakuramoto, Hideaki ^a,b   Hagiya, Keiichi ^a,b   Kawano, Satoru ^a,b   Mizutani, Taro ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Endothelin; Endotoxemia; Kidney; Landiolol hydrochloride; Rat model

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CREATININE; ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LANDIOLOL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; MESSENGER RNA; MORPHOLINE DERIVATIVE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; RAT; RAT MODEL; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; KIDNEY; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; ENDOTOXEMIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION MEDIATORS; KIDNEY; LIPOPOLYSACCHARIDES; MALE; MORPHOLINES; RATS, WISTAR; RNA, MESSENGER; UP-REGULATION; UREA;

EID: 84942585836     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.05.007     Document Type: Article

References (43)

1. Battistini, B., Forget, M.A., Laight, D., Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock 5 (1996), 167–183.
2. Bellomo, R., Wan, L., Langenberg, C., Ishikawa, K., May, C.N., Septic acute kidney injury: the glomerular arterioles. Contrib Nephrol 174 (2011), 98–107.
3. Cohen, J., The immunopathogenesis of sepsis. Nature 420 (2002), 885–891.
4. El Housseini, Y., Schmidtko, J., Meier, P., Neutrophil gelatinase-associated lipocalin as a new diagnostic tool for acute kidney injury. Rev Med Suisse 9 (2013), 2101–2106.
5. Greven, J., Gabriëls, G., Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function. Arzneimittelforschung 50 (2000), 973–979.
6. Gupta, A., Berg, D.T., Gerlitz, B., Richardson, M.A., Galbreath, E., Syed, S., et al. Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. Am J Physiol Renal Physiol 293 (2007), 245–254.
7. Hagiwara, S., Iwasaka, H., Maeda, H., Noguchi, T., Landiolol, an ultrashort-acting beta1-adrenoceptor antagonist, has protective effects in an LPS-induced systemic inflammation model. Shock 31 (2009), 515–520.
8. Han, M., Li, Y., Liu, M., Li, Y., Cong, B., Renal neutrophil gelatinase associated lipocalin expression in lipopolysaccharide-induced acute kidney injury in the rat. BMC Nephrol, 13, 2012, 25.
9. He, H.B., Dai, D.Z., Dai, Y., CPU0213, a novel endothelin receptor antagonist, ameliorates septic renal lesion by suppressing ET system and NF-kappaB in rats. Acta Pharmacol Sin 27 (2006), 1213–1221.
10. Hotchkiss, R.S., Karl, I.E., The pathophysiology and treatment of sepsis. N Engl J Med 348 (2003), 138–150.
11. Iguchi, S., Iwamura, H., Nishizaki, M., Hayashi, A., Senokuchi, K., Kobayashi, K., et al. Development of a highly cardioselective ultra short-acting β-blocker, ONO-1101. Chem Pharm Bull (Tokyo) 40 (1992), 1462–1469.
12. Jesmin, S., Gando, S., Matsuda, N., Sakuma, I., Kobayashi, S., Sakuraya, F., et al. Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 92 (2004), 966–979.
13. Jesmin, S., Gando, S., Zaedi, S., Sakuraya, F., Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis. Thromb Haemost 96 (2006), 830–838.
14. Jesmin, S., Gando, S., Zaedi, S., Sakuraya, F., Differential expression, time course and distribution of four PARs in rats with endotoxin-induced acute lung injury. Inflammation 30 (2007), 14–27.
15. Koyner, J., Garg, A., Coca, S., Sint, K., Thiessen-Philbrook, H., Patel, U.D., et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 23 (2012), 905–914.
16. Langenberg, C., Wan, L., Egi, M., May, C.N., Bellomo, R., Renal blood flow in experimental septic acute renal failure. Kidney Int 69 (2006), 1996–2002.
17. Lopes, J.A., Jorge, S., Resina, C., Santos, C., Pereira, A., Neves, J., et al. Acute renal failure in patients with sepsis. Crit Care, 11, 2007, 411.
18. Martin, G.S., Mannino, D.M., Eaton, S., Moss, M., The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003), 1546–1554.
19. Mio, Y., New ultra-short-acting beta-blockers: landiolol and esmolol-the effects on cardiovascular system. Masui 55 (2006), 841–848.
20. Mishra, J., Dent, C., Tarabishi, R., Mitsnefes, M.M., Ma, Q., Kelly, C., et al. Neutrophil gelanitane-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005), 1231–1238.
21. Motomura, S., Hagiwara, A., Narumi, Y., Hashimoto, K., Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmol and propranolol by using the canine isolated, blood-perfused heart preparations. J Cardiovasc Pharmacol 31 (1998), 431–440.
22. Murugan, R., Karajala-Subramanyam, V., Lee, M., Yende, S., Kong, L., Carter, M., et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 77 (2010), 527–535.
23. Norman, J.G., Fink, G.W., Franz, M.G., Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 130 (1995), 966–970.
24. Palevsky, P.M., Zhang, J.H., O'Connor, T.Z., Chertow, G.M., Crowley, S.T., Choudhury, D., et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 (2008), 7–20.
25. Palm, F., Hansell, P., Ronquist, G., Waldenstrom, A., Liss, P., Carlsson, P.O., Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47 (2004), 1223–1231.
26. Pittet, J.F., Morel, D.R., Hemsen, A., Gunning, K., Lacroix, J.S., Suter, P.M., et al. Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213 (1991), 261–264.
27. Plosker, G.L., Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. Drugs 73 (2013), 959–977.
28. Richter, C.M., Role of endothelin in chronic renal failure-developments in renal involvement. Rheumatology (Oxford) 45 (2006), Siii36–Siii38.
29. Sasser, J.M., Sullivan, J.C., Hobbs, J.L., Yamamoto, T., Pollock, D.M., Carmines, P.K., et al. Endothelin A receptor blockage reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 18 (2007), 143–154.
30. Schildroth, J., Rettig-Zimmermann, J., Kalk, P., Steege, A., Fahling, M., Sendeski, M., et al. Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice. Nephrol Dial Transplant 26 (2011), 779–789.
31. Schrier, R.W., Wang, W., Acute renal failure and sepsis. N Engl J Med 351 (2004), 159–169.
32. Sharfuddin, A.A., Weisbord, S.D., Palevsky, P.M., Molitoris, B.A., Acute kidney injury. Taal, M.W., Chertow, G.M., Marsdeb, P.A., Skorecki, K., Yu, A.L., Brenner, B.M., (eds.) Brenner & Rector's the Kidney, 9th ed, 2012, Elsevier Saunders, 1053–1055.
33. Shimojo, N., Jesmin, S., Zaedi, S., Maeda, S., Gando, S., Yamaguchi, I., et al. Alterations of gene expressions of preproET-1 and ET receptors in brains of endotoxemic Sprague–Dawley rats. Exp Biol Med 231 (2006), 1058–1063.
34. Shimojo, N., Jesmin, S., Zaedi, S., Otsuki, T., Maeda, S., Yamaguchi, N., et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol 293 (2007), 474–481.
35. Song, R., Kim, J., Yu, D., Park, C., Park, J., Kinetics of IL-6 and TNF-α changes in a canine model of sepsis induced by endotoxin. Vet Immunol Immunopathol 146 (2012), 143–149.
36. Taenaka, N., Kikawa, S., The effectiveness and safety of landiolol hydrochloride, an ultra-short-acting beta1-blocker, in postoperative patients with supraventricular tachyarrhythmias: a multicentre, randomized, double-blind, placebo-controlled study. Am J Cardiovasc Drugs 13 (2013), 353–364.
37. Takakuwa, T., Endo, S., Nakae, H., Kikichi, M., Suzuki, T., Inada, K., et al. Plasma levels of TNF-alpha, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol 84 (1994), 261–269.
38. Vandijck, D., Decruyenaere, J.M., Blot, S.I., The value of sepsis definitions in daily ICU-practice. Acta Clin Belg 61 (2006), 220–226.
39. Weir, M.R., Hanes, D.S., Klassen, D.K., Antihypertensive drugs. Taal, M.W., Chertow, G.M., Marsdeb, P.A., Skorecki, K., Yu, A.L., Brenner, B.M., (eds.) Brenner & Rector's the kidney, 9th ed., 2012, Elsevier Saunders, 1835–1841.
40. Wu, L., Tiwari, M.M., Messer, K.J., Holthoff, J.H., Gokden, N., Brock, R.W., et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol 292 (2007), 261–268.
41. Yamaguchi, N., Jesmin, S., Zaedi, S., Shimojo, N., Maeda, S., Gando, S., et al. Time-dependent expression of renal vaso-regulatory molecules in LPS-induced endotoxemia in rat. Peptides 27 (2006), 2258–2270.
42. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988), 411–415.
43. Yang, X., Sun, C., Anderson, T., Moran, C.M., Hadoke, P.W., Gray, G.A., et al. Assessment of spectral Doppler in preclinical ultrasound using a small-size rotating phantom. Ultrasound Med Biol 39 (2013), 1491–1499.